Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02607514 · ClinicalTrials.gov registry record · NA

Hyperthermic Yoga for Depressive Symptoms

A NA study of Depression and Major Depressive Disorder, sponsored by Massachusetts General Hospital.

Completed
Registry status
NA
Development phase
80
Enrollment target
1
Study location

NCT02607514 is a NA study of Depression and Major Depressive Disorder that has completed, run by Massachusetts General Hospital. The registered enrollment target is 80 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02607514, a NA study of Depression and Major Depressive Disorder, has completed, sponsored by Massachusetts General Hospital.

COMPLETED
Registry status
NA
Development phase
80 participants
Enrollment target
1
Study location

Study Summary

Study is a randomized controlled trial to assess the feasibility, acceptability, efficacy, and mechanisms of action of hyperthermic yoga versus a waitlist control for 80 medically healthy adults with mild to moderate depressive symptoms. The primary aim is to test the acceptability and feasibility of hyperthermic yoga as a treatment for depression. The secondary aim is to examine the effect size/efficacy of hyperthermic yoga for depressive symptoms. The tertiary aim is to explore physiological and psychological mechanisms of action.

Interventions

  • BEHAVIORAL hyperthermic yoga

Study Locations (1)

Massachusetts

  • Depression Clinical and Research Program - Boston

Trial Details

FieldValue
Enrollment Target 80 participants
Start Date 2017-02-20
Est. Completion 2019-12-19
Phase NA

Sponsor

Massachusetts General Hospital

2,032 total trials

What the Registry Record Tells You About NCT02607514

The ClinicalTrials.gov registry entry for NCT02607514 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 786-participant average among 679 other Depression trials with a reported enrollment target (90% lower). The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Depression appearing as the primary indexed condition, and to 1 intervention - of which hyperthermic yoga is the first listed.

NCT02607514 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT02607514 about?

NCT02607514 is a clinical study titled "Hyperthermic Yoga for Depressive Symptoms". Study is a randomized controlled trial to assess the feasibility, acceptability, efficacy, and mechanisms of action of hyperthermic yoga versus a waitlist control for 80 medically healthy adults with mild to moderate depressive symptoms. The primary aim is to test the acceptability and feasibility o...

What is the current status of trial NCT02607514?

This trial is currently completed. It is a NA study. The enrollment target is 80 participants. The study started on 2017-02-20. Estimated completion is 2019-12-19.

What conditions does trial NCT02607514 study?

This clinical trial studies the following conditions: Depression, Major Depressive Disorder.

What interventions are being tested in trial NCT02607514?

The interventions under investigation include: hyperthermic yoga (BEHAVIORAL).

Who is sponsoring clinical trial NCT02607514?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02607514 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Depression

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.